Tel: 1-909-396-6530 USA
Fax: 1-909-474-8856 USA

Online Skype / Yahoo IM
 user name:
Nutrimartus

   
  HomeBrand NamePopular ProductBargain BuyNew ProductsBulk Raw MaterialsView CartContact
Ailments InfoVitamins & Minerals InfoAmino Acids InfoNutrition-LibraryHomeopathy FAQPrivacy PolicyChinese
 

 
 

          Combine Search


 
  

                  


 

ANTI-DIABETIC

GYMNEMA SYLVESTRE

Written by Dr. Kumar Pati

Courtesy extracted from Herbal World

According to Dr. Baskaran and Dr. Ahamath, of the Department of Biochemistry, Post-Graduate Institute of Basic Medical Sciences, Madras, India, the therapeutic properties of Gymnema sylvestre, an extract from the leaves of Gymnema sylvestre, in controlling hyperglycaemia was investigated in 22 Type-2 diabetic patients on conventional oral anti-hyperglycaemic agents. Gymnema sylvestre, (400 mg/day) was administered for 18-20 months as a supplement to the conventional oral drugs.

During Gymnema sylvestre supplementation, the patients showed a significant reduction in blood glucose, glycosylated haemolglobin and glycosylated plasma proteins, and conventional drug dosage could be decreased. Five of the 22 diabetic patients were able to discontinue their conventional drug and maintain their blood glucose homeostasis with Gymnema sylvestre alone. These data suggest that the beta cells may be regenerated/repaired in Type-2 diabetic patients on Gymnema sylvestre supplementation. This is supported by the appearance of raised insulin levels in the serum of patients after Gymnema sylvestre supplementation.


Type-2 NIDDM, (non-insulin dependent) diabetes mellitus, is among the most common disorders in developed and developing countries, which report that abnormalities of beta cell function and secretion exist in patients with non-insulin.

Control of blood glucose on a 24-hour basis is the desired goal in the management of diabetes mellitus, so as to prevent or delay the onset of the secondary complications of diabetes mellitus. Dieting, physical exercise and inclusion of dietary fibre have been used with limited success.
Oral anti-hyperglycaemic drugs play an important role in the treatment of Type-2 diabetes mellitus. There are two groups of oral anti-hyperglyceamic agents available for clinical use, i.e. the sulfonylureas and biguanides. The sulfonylureas are reported to regulate blood glucose homeostasis by stimulating pancreatic secretion of insulin. Both have a characteristic profile of side effects.
Many investigations of the oral anti-hyperglycemic agents of plant origin used in traditional medicine have been conducted. One such preparation proven effective in diabetes mellitus is an extract of the leaves of Gymnema sylvestre.

Sushruta (6th Century B.C.) and practitioners of Ayurveda in ancient India have recommended the use of the leaves of the 'sala saradi' group and it has been described in Indian Medicinal Plants.
GS, an extract from Gymnema sylvestre, has been shown to regenerate the islets of Langerhans, especially the beta cells, in both streptozotocin and alloxan-treated rats.
GS, the water-soluble acidic fraction of an ethanol extract of the leaves of Gymnema sylvestre, was tested by oral administration (400 mg/day, packed in a hard gelatin capsule) to 22 Type-2 diabetic patients.

"Because of many clinical trials,
Gymnema sylvestre is used today
all over India
for treating diabetes mellitus."



Patients were enlisted for GS therapy after informed consent, and were enlisted at various stages. All had been on conventional therapy by the time the present study was instituted. The 22 patients were instructed to take their conventional therapy in addition to GS capsules.

The patients were in the age group of 40 to 62 years and 3 were on tolbutamide. The duration of diabetes varied from 1 to 12 years and the average was 4.6 years. Blood glucose was adjusted to prevent hypoglycaemic episodes.

Blood and urine analysis were made periodically in both groups. Venous blood samples were drawn under fasting conditions from the patients into tubes containing the disodium salt of ethylene diamine tetraacetic acid (EDTA) as anticoagulant. Plasma was separated by decantation after centrifugation of blood and sugar for the assay of glycosylated plasma proteins.

Serum insulin assay was conducted using 15 healthy adults, 15 cases of NIDDM after 18-20 months of GS supplementation. Eight volunteers provided a second sample 90 minute after their usual breakfast providing 600-650 calories and this was labelled in the post-prandial sample.
To assess the effectiveness of GS as an instant blood glucose lowering agent, 12 adult healthy volunteers were administered 200 mg GS under fasting state, after blood sampling in the morning. Blood samples were collected 45 minutes after GS administration and blood glucose was assayed in both samples.

"Five out of the 22 NIDDM
patients on GS supplementation
were able to discontinue
their conventional drugs
after GS supplementation."



Most of the patients reported a sense of well-being and better alertness and less exhaustion during work, during GS supplementation. The female patients reported that the nagging pain in their limbs disappeared within 4 weeks of GS supplementation. The blood glucose, glycosylated haemoglobin and glycosylated plasma proteins were significantly lower after GS supplementation. Five out of the 22 NIDDM patients on GS supplementation were able to discontinue their conventional drugs after GS supplementation and were able to maintain their blood glucose homeostasis with GS alone.
Blood urea, uric acid and haemoglobin levels remained in the normal range during GS supplementation, suggesting the absence of hepato or nephrotoxicity for GS.

It can be observed that serum insulin levels are lower than normal in NIDDM patients on conventional drugs in both fasting and in the post-prandial state, which provides data on glucose induced insulin release. However, when the group on GS supplementation is compared with those on conventional therapy alone, there is a significant elevation of serum insulin in both the fasting and post-prandial state.

Because of many clinical trials, Gymnema sylvestre is used today all over India for treating diabetes mellitus. In layman's language, it is called GUR MAR. Gur means sugar and Mar means kill. So it is a powerful herbal sugar killer for diabetes mellitus patients. In order to reduce the symptoms of glycosuria, the dried leaves are used in various forms such as hot tea in daily doses of three to four grams continuously. HW


 

NutriMart does not warrant the accuracy of the information or guarantee the claims, benefits or safety of specific products sold. The claims made about specific products have not been evaluated by the Food and Drug Administration, Even though  the products maybe claimed as its traditional usage.  Please consult with a healthcare professional before starting any diet, exercise or supplementation program